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AbstrAct
Objective To examine implementation of evidence in 
orthopaedic practice following publication of the results 
of three pivotal clinical trials.
Design Case studies based on three orthopaedic 
trials funded in sequence by the National Institute for 
Health Research Health Technology Assessment (HTA) 
programme. These trials dealt with treatment of fractures 
of the humerus, radius and ankle, respectively. For 
each case study, we conducted time- series analyses to 
examine the relationship between publication of findings 
and the implementation (or not) of the findings.
Results The results of all three trials favoured the 
less expensive and less invasive option. In two cases, 
a change of practice, in line with the evidence that 
eventually emerged, preceded publication. Furthermore, 
the upturn in use of the intervention most supported 
by each of these two trials corresponded to the start of 
recruitment to the respective trial. The remaining trial 
failed to influence practice despite yielding clear- cut 
evidence.
Conclusions Implementation of results of all three HTA 
orthopaedic trials favoured the less expensive and less 
invasive option. In two of the three studies, a change 
in practice, in line with the evidence that eventually 
emerged, preceded publication of that evidence. A trend 
or a change in practice, at around the start of the trial, 
indicates that the direction of causation opposes our 
hypothesis that publication of trial findings would lead 
to changes in practice. Our results provide provocative 
insight into the nuanced topic of research and practice, 
but further qualitative work is needed to fully explain 
what led to the pre- emptive change in practice we 
observed and why there was no change in the third case.
IntroductIon
Evidence- based healthcare relies on clin-
ical trials to inform practice and policy. In 
England, the National Institute for Health 
Research (NIHR) Health Technology 
Assessment (HTA) programme reports 
the findings of clinical trials. The uptake 
of the results of surgical trials in clinical 
practice can be inexpensively monitored 
by means of routinely collected hospital 
data.1 Over the past decade, there have 
been three large, multicentre randomised 
trials in musculoskeletal trauma in the UK 
funded by the NIHR HTA programme: 
Distal Radius Acute Fracture Fixation 
Trial (DRAFFT),2 Proximal Fracture of 
the Humerus: Evaluation by Randomi-
sation (ProFHER)3 and Ankle Injury 
Management (AIM).4
The DRAFFT was a large, multicentre 
trial evaluation of volar locking- plate with 
the less invasive method of Kirschner wire 
(K- wire) fixations in the treatment for 
fractures of the distal radius. The study 
did not detect any advantage for the more 
invasive and expensive plate fixation.2 
The ProFHER trial provided robust, 
clinically relevant evidence showing that 
current surgical practice does not result 
in a better outcome for patients with 
selected displaced fractures of the prox-
imal humerus, and hence that it is not 
cost- effective.3 The AIM trial compared 
open reduction and internal fixation with 
close contact casting (CCC), for ankle 
fracture. This study found no advan-
tage from surgery to counterbalance the 
obvious side effects and disadvantages 
of invasive treatment.4 In short, all three 
study findings supported use of the less 
invasive over the more invasive alter-
native. Table 1 gives an overview of the 
three reports considered in this paper. 
Each describes a randomised controlled 
trial comparing two treatment types for 
a diagnosis. The aim of HTA reports is 
to provide practitioners with evidence on 
which to base practice and policy changes. 
Although the reports do not make recom-
mendations for practice, the results were 
clear cut in terms of the rationale for 
these publicly funded studies. The NIHR 
Collaboration for Leadership in Applied 
Health Research and Care (CLAHRC) 
West Midlands and NIHR CLAHRC East 
Midlands joined forces to monitor the 
extent to which the findings from these 
trials might have influenced practice.
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Table 1 Summary of HTA study findings
Title
Distal Radius Acute Fracture 
Fixation Trial
Proximal Fracture of the Humerus: 
Evaluation by Randomisation trial Ankle Injury Management trial
Intervention group K- wires Non- surgical Surgical
Control group Locking plate Surgical CCC
Age group Aged ≥18 Aged ≥16 Aged ≥60
Trial size 461 participants recruited
K- wires: 230
Locking plate: 231
250 participants recruited
Surgery: 125
Conservative treatment: 125
620 participants recruited
ORIF: 309
CCC: 311
Primary outcome Patient- rated wrist evaluation 
questionnaire at 12 months after the 
fracture
Oxford Shoulder Score assessed at 6, 12 and 
24 months
Olerud- Molander Ankle Score at 6 
months
Secondary outcome    ►  12- item Short Form health survey
 ►  Surgical and other shoulder fracture- related 
complications
 ►  Secondary surgery to the shoulder or 
increased/new shoulder- related therapy
 ►  Medical complications during inpatient stay
 ►  Mortality
 ►  Quality of life (as measured by the 
European Quality of Life 5- Dimensions, 
Short Form questionnaire-12 items)
 ►  Pain
 ►  Ankle range of motion and mobility (as 
measured by the timed up and go test)
 ►  Patient satisfaction
 ►  Radiological measures
Favoured treatment K- wires Non- surgical CCC
CCC, close contact casting;HTA, Health Technology Assessment; ORIF, open reduction and internal fixation.
Methods
data collection
In order to track the uptake of the treatments recom-
mended in these three reports, we used data from the 
Hospital Episode Statistics (HES) database, which 
enabled us to plot the frequency of treatment types for 
specific diagnoses over time, beginning in 2003. The 
HES dataset contains details of all emergency and elec-
tive inpatient admissions, outpatient appointments and 
Accident and Emergency (A&E) attendances funded 
by the National Health Service (NHS) in England.
Identifying the correct diagnosis and treatment 
codes from the descriptions given in HTA reports 
proved challenging because terms used in the report 
are not necessarily the same as the codes used in the 
HES database (table 2). We sought expert advice from 
specialists, which enabled us to link the indication for 
surgery and type of surgery in HES to descriptions in 
the HTA report. Patients were filtered according to 
age and diagnosis in line with the descriptions given, 
and frequencies of treatment types were aggregated by 
6- month intervals. After patients had been filtered by 
age and diagnosis, the earliest admission was retained 
and all subsequent admissions were excluded, in line 
with ‘intention to treat’ principles. Records in HES are 
given ICD-10 (International Classification of Disease, 
10th revision) diagnosis codes and OPCS-4 (Office 
of Population Censuses and Surveys classification of 
interventions and procedures) procedure codes.
All three HTA reports specified the age of partici-
pants in the trial. In order to select patients who are 
as similar as possible to those in the trial, the age of 
patients was restricted accordingly. Patients were over 
18 for DRAFFT, over 16 for ProFHER, and over 60 
for AIM.
The data for the ProFHER trial (fractured humerus) 
starts at 2011. We did not collect earlier evidence 
because we have included patients who received non- 
surgical treatment in the A&E department, and A&E 
data were not included in HES until 2011.
CCC (AIM trial) is a relatively new technique used to 
maintain reduction of an ankle fracture. It is a modifica-
tion of the total contact cast, which is regularly used to 
treat leg ulcers in diabetic patients.3 Our original plan 
for this analysis was to track the number of CCC treat-
ments per 6- month interval and find whether this had 
risen as a percentage of the total, as in the analysis for 
the DRAFFT and ProFHER trials. However, it became 
apparent that differentiating between CCC and a tradi-
tional cast would be very difficult due to coding limita-
tions. In an effort to identify the operation codes being 
used for this type of procedure, we looked at more 
detailed operating theatre data for University Hospi-
tals Birmingham NHS Foundation Trust and searched 
for operation descriptions containing “closed contact 
cast”. Unfortunately, only seven procedures contained 
this description, all with different operation codes. 
Since we know that this procedure is commonly used 
for older patients, this is unlikely to reflect the true 
frequency of the use of CCC and therefore limits our 
ability to track it over time. We describe our approach 
to this limitation below.
Analysis
After plotting the frequency of different treatment 
types at 6- month intervals, we calculated the frequency 
of the recommended treatment as a percentage of the 
total, as described in table 3. For the first two trials, 
we were able to calculate the number of procedures 
as a percentage of the total. However, due to the 
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Table 2 Data extraction codes
DRAFFT
Diagnosis S52.5—Fracture of lower end of radius
S52.6—Fracture of lower end of both ulna and radius
Operation Relevant operations in W1, W2 and W3 with Z70.5—
Lower end of radius NEC
ProFHER   
Diagnosis S42.2—Fracture of upper end of humerus
Operation A&E 36—Sling/collar cuff/broad arm 
sling
Inpatients Surgical Relevant 
operations in W 
(other bones and 
joints)
Non- surgical X49.5—
Application 
of sling NEC 
with one of 
the following: 
Z69.1—Head 
of humerus, 
Z69.2—
Tuberosity 
of humerus, 
Z69.3—Neck of 
humerus
AIM   
Diagnosis S82.5—Fracture of medial malleolus
S82.6—Fracture of lateral malleolus
S82.8—Fractures of other parts of lower leg
Operation Relevant operations in W (other bones and joints)
Operation 
restrictions
Z85.6—Ankle joint, ie, fractures of lower leg 
excluded if ankle not involved
See online supplementary appendix for more detailed codes.
A&E, Accident and Emergency; AIM, Ankle Injury Management; 
DRAFFT, Distal Radius Acute Fracture Fixation Trial; NEC, Not Elsewhere 
Classified; ProFHER, Proximal Fracture of the Humerus: Evaluation by 
Randomisation.
Table 3 Numerators and denominators for percentages
Trial Numerator Denominator
DRAFFT No of K- wire, locking plate or 
other procedures for patients 
with fracture of the lower end 
of the radius
Total no of procedures for 
patients with fracture of 
the lower end of the radius
ProFHER No of surgical or non- surgical 
procedures for patients with 
fracture of the upper end of the 
humerus
Total no of procedures 
for patients with fracture 
of the upper end of the 
humerus
AIM No of surgical procedures for 
patients with ankle fractures
n/a (see above text)
AIM, Ankle Injury Management; DRAFFT, Distal Radius Acute Fracture 
Fixation Trial; n/a, not applicable; ProFHER, Proximal Fracture of the 
Humerus: Evaluation by Randomisation.
data limitations in the third trial, we were unable to 
calculate the total including CCC procedures, so we 
could only analyse the denominator- free frequency of 
surgical procedures.
In order to check whether there was a significant 
change in the frequency over time, we fitted a linear 
model to the time series and used a cumulative sum 
test to find whether this linear model fitted the data. 
The null hypothesis was that the cumulative sum of 
recursive residuals would have an expected value of 
0. If it moves outside of the 95% confidence band at 
any point in time, it indicates that the coefficients have 
changed and a single linear model does not fit the data. 
If this was the case, we wanted to find whether the 
change (or break point) in the data coincided with the 
publication date of the HTA report. The date of the 
break in the model was identified using a Wald test 
and separate linear models were fitted before and after 
this date.
Patient involvement
No patients were involved in setting the research ques-
tion or the outcome measures, nor were they involved 
in developing plans for recruitment, design or imple-
mentation of the study. No patients were asked to 
advise on interpretation or writing up of results. There 
are no plans to disseminate the results of the research 
to study participants or the relevant patient commu-
nity.
results
distal radius Acute Fracture Fixation trial
In the years 2003–2017, there were 151 951 admis-
sions for patients who were aged 18 or over, had a 
fracture of the lower end of the radius and received 
one of the emergency treatment types of interest. 
Four thousand four hundred and sixty- one admis-
sion records were excluded because it was a second 
or higher order admission for a patient with multiple 
admissions, so exclusion was on an intention- to- treat 
basis. This brought the total number of admissions 
down to 147 490 (an average of 4916 every 6 months).
Figure 1A illustrates the frequency of treatments 
categorised as K- wire fixation, plate fixation and other. 
The trial began in July 2010 and the report with the 
findings was published in February 2015. Figure 1B 
illustrates the number of K- wire fixation treatments as 
a percentage of the total. A cumulative sum test indi-
cates that a linear fitted model does not fit the data 
(test statistic=1.2858 with critical value=0.9479), 
and an estimated structural break corresponding to 
the first half of 2012 is given at the first 6 months in 
2012 (p=0.000, Supremum Wald statistic=62.1275). 
The increase in use of the recommended treatment 
preceded publication of trial results and the upturn 
started at approximately the same time as the trial.
Proximal Fracture of the humerus: evaluation by 
randomisation
In the years 2011–2017, there were 13 628 admissions 
for patients who were aged 16 or over and had a frac-
ture of the upper humerus. One hundred and sixty- one 
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Figure 1 (A) Frequency of treatment types for displaced distal radius fractures: Distal Radius Acute Fracture Fixation Trial (DRAFFT). (B) K- wire fixation 
treatment as a percentage of the total for displaced distal radius fractures: DRAFFT. HES, Hospital Episode Statistics; HTA, Health Technology Assessment.
admission records were excluded because the patient 
had more than one admission with the same diag-
nosis, so exclusion was on an intention- to- treat basis. 
This brought the total number of admissions down 
to 13 467 (an average of 962 every 6 months). The 
trial began in March 2008 and the HTA report was 
published in March 2015.
Figure 2A illustrates the frequency of treatments 
categorised as sling or surgery. Figure 2B illustrates the 
number of patients treated with a sling as a percentage 
of the total. A cumulative sum test indicates that a linear 
fitted model does fit the data (test statistic=0.6070 
with critical value 0.9479). Although there is no clear 
break in the data, the less invasive procedure increased 
from the start of the trial, flattening off after the trial 
was published.
Ankle Injury Management
In the years 2003–2017, there were 9638 admissions 
for patients who were aged 60 or over, had an ankle 
fracture and received surgical treatment for ankle 
fractures of the type that were examined in the trial. 
Fifty- five admission records were excluded because the 
patients had subsequent admissions for the same diag-
nosis, so exclusion was on an intention- to- treat basis. 
This brought the total down to 9583 (an average of 
319 every 6 months). The trial began in January 2010 
and the HTA report was published in October 2016. 
Figure 3 illustrates the frequency of surgical oper-
ations. A cumulative sum test indicates that a linear 
fitted model does fit the data (test statistic=0.7567 
with critical value=0.9479). In this study, there was no 
‘anticipation’ of the results at the inception of the trial, 
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Figure 2 (A) Frequency of treatment types for proximal fracture of the humerus: Proximal Fracture of the Humerus: Evaluation by Randomisation 
(ProFHER) trial. (B) Sling treatment as a percentage of the total for proximal fracture of the humerus: ProFHER trial. HTA, Health Technology Assessment.
nor does practice change in line with the published 
findings. Despite the finding that surgical interven-
tion is no more effective than non- surgical care, the 
increase in operations seen during the trial continues 
after publication of the findings.
dIscussIon
Main findings
Trial results of all three cases favoured the less expen-
sive and invasive option. In none of the three case 
studies did implementation of the treatment favoured 
by the trial increase after publication of the report. In 
two of the studies, a change in line with the evidence 
that eventually emerged preceded the publication of 
the findings and increased throughout the trial period.
Distal Radius Acute Fracture Fixation Trial
A previous review of the impact of the DRAFFT by 
Costa et al5 used graphical summaries to find whether 
the frequency of each treatment type changes around 
the time of the trial. Unfortunately, the authors were 
unable to track use of the different procedures after 
the report publication in 2015 since their data ended 
in 2014. They do, however, see changes in frequency 
around the start of the trial in 2010 in the direction 
recommended by the results. It was not possible to 
replicate their methods because we could not replicate 
the codes they used. However, our findings agree with 
those of Costa et al,5 showing that the frequency of 
using a plate started to fall after 2010, with a corre-
sponding increase in the use of K- wires.
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Figure 3 Frequency of surgery for patients aged over 60 with unstable ankle fractures: Ankle Injury Management (AIM) trial. HTA, Health Technology 
Assessment.
Proximal Fracture of the Humerus: Evaluation by Randomisation
The recommendations made in the ProFHER report3 
are certainly reflected in the data, with the use of slings 
as treatment for proximal humerus fractures consist-
ently rising in both frequency and as a percentage of 
the total. However, this trend started before the start 
of the trial and certainly before publication of the 
report, implying that this may be another case where 
the results of the trial only confirmed the changes 
that were already taking place in practice. The trial 
reflects a growing consensus over the past few years 
that conservative treatment methods are preferable to 
surgery for many, but not all, patients with fracture of 
the humerus.
Ankle Injury Management
We were unable to track the proportion of CCC proce-
dures among eligible patients. However, the crude 
surgery frequencies indicate that there is no statisti-
cally significant break in use of the procedure.
limitations
Our study has several limitations. It is an associa-
tion study and a change in practice (in any direction) 
cannot be attributed to any particular causal hypoth-
esis, beyond that showing or disproving a temporal 
trend. Follow- up beyond the publication of the study 
is short (only a year in one case). The findings from 
these three orthopaedic trials cannot be generalised 
to all orthopaedic trials, let alone all surgery trials or 
all clinical trials. They simply illustrate an association 
between the conduct of a trial and a change in practice 
in two case studies, and no immediate change in prac-
tice following publication of the third case.
Failure of trial results to influence practice
A number of frameworks have been proposed to 
improve implementation of new knowledge resulting 
in adoption or abandoning a particular interven-
tion.6 They start with the identification of a problem 
that needs to be solved. Then, if failure to imple-
ment knowledge is identified, the following steps are 
proposed: problem analysis (identification of barriers 
and facilitators); develop a theory of how to remedy 
the problem; work with stakeholders to develop an 
intervention; implement the intervention; and eval-
uation—a process similar to the Medical Research 
Council strategy for evaluation of complex interven-
tions.7 Our study answers the first question—has the 
evidence been implemented—and does so at a national 
scale. The next step will be to explain why evidence 
obtained at considerable cost has not been widely 
implemented. Adapting Grol and Grimshaw,8 this may 
be because
1. The evidence was considered to be at risk of bias. These 
publicly funded studies were all heavily refereed prior 
to funding and again before publication. They were well 
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designed but have the limitation inherent in most surgi-
cal studies that patients and surgeons were not masked to 
allocated group. The trials comply with the recommen-
dations of the Balliol collaboration.9–11
2. The surgeons may have specific views about generalis-
ability and applicability of results to special classes of 
patients. Such patient selection would be an acceptable 
reason for a limited change in practice overall, but it 
somewhat vitiates the rationale for the trial if used to 
explain no change in practice at all.
3. The nature of the intervention. Some interventions are 
more likely to lead to practice change than others, and 
those that require giving up a technique that one has 
mastered will be harder for people to relinquish than 
an intervention, such as a medicine, in which the practi-
tioner may be less ‘invested’.
4. Whether the treatment is in the ‘gift’ of the clinician, 
or whether new funding must be provided or pathways 
changed. In the case of the favoured intervention in these 
studies, the required service disruption is minimal and 
the favoured treatment less expensive than the alterna-
tive. The exception here might be close contact casting, 
which requires that plaster technicians should be trained 
in this technique, and where cast changes are required.
5. Complex trade- offs and varying preferences creating 
‘split- choice’ decisions,12 where some patients may have 
specific preferences, say to avoid the inconvenience asso-
ciated with a cast.
6. Inertia. Sometimes people are ‘in a groove’ and are 
not opposed to change; they are just not motivated to 
change. Such people need a ‘nudge’, perhaps from a re-
spected organisation, such as the National Institute for 
Health and Care Excellence or their Royal College. One 
may speculate that lack of such endorsement is a factor 
in the cases considered here.
‘Anticipation’ of study results
It would be tempting, particularly in the two cases 
where there was a change in practice before or at the 
start of the trial, to attribute the former to the latter. 
However, it is arguably more convincing to attribute 
the existence of the trial and the observed system- wide 
change in practice to the same ‘external’ factors. This 
finding, that practice across a system anticipates study 
results, has been described previously as a ‘rising tide 
phenomenon’.13 The ‘rising tide’ refers to a broad 
temporal trend where a community of practitioners 
come under a common influence that is both the cause 
of a study and of a more general change in practice. 
Orthopaedic surgeons are exposed to many influences 
that can explain this ‘rising tide’ effect. Discussions 
among surgeons in the period leading up to a trial may 
soften previous convictions, and the fact that the trial 
has been funded may provide further endorsement 
for an option the surgeon would not otherwise use. 
Orthopaedic surgeons, like other clinicians, may have 
become more willing to accept the less invasive of two 
therapies as the default procedure, as the concept of 
opportunity costs diffuses in society. A trial itself will 
always increase the use of the lesser used of any two 
comparator treatments, but this explanation cannot 
account for the magnitude of changes observed in 
the DRAFFT and ProFHER studies since only a small 
proportion of the nation’s hospitals participated in the 
trial.
next steps
The study we report here should be expanded in depth 
and in breadth. Depth should be extended by exam-
ining the literature for other trials/systematic reviews 
and by qualitative interviews to explore the reasons 
for findings. Breadth should be extended by tracking 
the correlation between the start and publication of 
other trials that were designed to change practice. In 
the meantime, our results provide provocative insight 
into the nuanced topic of research and practice. The 
results presented here show evidence of ‘anticipation’ 
or the ‘rising tide’ phenomenon.
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